Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

479
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
479
Glaucoma: Overview01:25

Glaucoma: Overview

621
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
621
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

560
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
560

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effect of intraocular pressure control on visual field progression in the HORIZON trial.

Ophthalmology. Glaucoma·2026
Same author

Evaluation of the Deep Reality Viewer for teaching slit-lamp examination of the anterior segment and the optic nerve head.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Comparative Outcomes of Standalone Xen63 Gel Stent and Preserflo Microshunt Implantation: A Multicenter Study.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

The Flip Sides of Interventional Glaucoma.

Ophthalmology. Glaucoma·2026
Same author

Structure-Function Correlation of Virtual Reality and Standard Perimetry With Peripapillary RNFL OCT in Glaucoma Patients.

Translational vision science & technology·2026
Same author

Follow-up after cataract surgery: a cross-sectional survey of Canadian practice patterns at a large surgical centre.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same journal

Aflibercept 24-Month Outcomes in Diabetic Macular Edema With and Without Prior Macular Laser Therapy: Data from the Fight Retinal Blindness! Registry.

Ophthalmology and therapy·2026
Same journal

Experiences and Perspectives on Diabetic Retinopathy Screening and Treatment in Mexico: A Subanalysis of the Diabetic Retinopathy Barometer Study.

Ophthalmology and therapy·2026
Same journal

Intraoperative Modified Peripheral Panretinal Photocoagulation in Proliferative Diabetic Retinopathy.

Ophthalmology and therapy·2026
Same journal

Topical Insulin for Corneal Persistent Epithelial Defects: A Multicenter Retrospective Study.

Ophthalmology and therapy·2026
Same journal

Identification of OCTA Biomarkers and Cutoff Values Associated with Disease Severity in Dry Age-Related Macular Degeneration.

Ophthalmology and therapy·2026
Same journal

Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg.

Ophthalmology and therapy·2026
查看所有相关文章

相关实验视频

Updated: Jul 19, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K

在眼中使用新的设备.

Lilian Chan1, Marlene R Moster2, Amanda K Bicket3

  • 1Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 North 39th St., Philadelphia, PA, 19104, USA.

Ophthalmology and therapy
|August 9, 2023
PubMed
概括
此摘要是机器生成的。

新型的微创视障装置为维护视力提供了新的治疗选择. 需要进一步的研究来证实它们在治疗青光眼的长期有效性.

关键词:
延迟作用的准备工作绝缘激光轨道切除术 (TRABECULOSTOMY) 是一种激光切除术.眼光障碍 眼光障碍 眼光障碍 眼光障碍青光眼的排水植入物植入物.在 MINI 投射器上.最少侵入性的玻璃眼外科手术.最少侵入性的微型硬化造形术.多重压力拨号表视觉板上有一个视觉板.这就是iDOSE DOSE.

更多相关视频

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.1K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.4K

相关实验视频

Last Updated: Jul 19, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.1K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.4K

科学领域:

  • 眼科医生 眼科 眼科
  • 医疗器械 医疗器械
  • 玻璃眼研究研究 玻璃眼研究

背景情况:

  • 玻璃眼是全球失明的主要原因之一.
  • 传统的治疗方法正在扩大,采用微创治疗技术.

研究的目的:

  • 审查用于绿眼病管理的新型设备.
  • 讨论新出现的治疗方案.

主要方法:

  • 关于新的和正在开发的玻璃眼设备的文献评论.
  • 根据作用机制对设备进行分类 (例如,增强外流,药物输送).

主要成果:

  • 针对下,施莱姆运河和上空间的设备的概述.
  • 包括持续释放药物输送和新型眼外器件.
  • 识别新上市或正在开发的设备.

结论:

  • 最少入侵的设备代表着格劳科马治疗的新兴领域.
  • 长期有效性和将其纳入临床实践需要进一步研究.